1787 Stories, most recent news story added Sat Nov 28, 7:12 am ET
Ghrelin, a hormone produced in the stomach, may be used to boost resistance to, or slow, the development of Parkinson's disease, Yale School of Medicine researchers report in a study published in a recent issue of the Journal of Neuroscience.Parkinson's disease is caused by a degeneration of dopamine neurons in an area of the midbrain known as the substantia nigra, which is responsible for ...
An Indiana State University professor specializing in human muscular movement will address the Terre Haute Parkinson’s Disease Support Group on Friday.
A naturally occurring stomach hormone shows promise in slowing the development of Parkinson's disease, researchers in Connecticut said.
Scientists have significantly advanced our understanding of dopamine release from nerve cells, findings that should speed the development of more effective drugs for treating Parkinson's disease. People with Parkinson's disease suffer from muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement. These primary symptoms are caused by the loss of ...
Australian scientists have significantly advanced our understanding of dopamine release from nerve cells, findings that should speed the development of more effective drugs for treating Parkinson's disease. People with Parkinson's disease suffer from muscle rigidity, tremor, a slowing of physical movement and, in extreme cases, a loss of physical movement. These primary symptoms are caused by ...
Eye problems are not unusual in people with Parkinson's disease . Dr Jay B Lavine is an ophthalmologist from Tucson, Arizona, USA, who has written a most helpful article in the latest Educational Supplement published by the American Parkinson Disease Association. We reproduce it in full here.
Dr. Sarit Larisch of the University of Haifa received the prestigious Johnson & Johnson Focus Funding grant for her breakthrough research exploring the cause of brain cell damage in Parkinson's disease.
A teacher at the prestigious Beacon HS in Manhattan who developed Parkinson's disease claims that coldhearted administrators launched a campaign to drive him out of the classroom rather than accommodate his disability. In a lawsuit filed in Manhat...
Ghrelin, a hormone produced in the stomach that stimulates hunger, may be used to boost resistance to, or slow the development of, Parkinson’s disease, Yale School of Medicine researchers are reporting.
GENEVA, SWITZERLAND--(Marketwire - November 24, 2009) - ADX48621 shows efficacy on both chorea and dystonia in PD-LID model Addex Pharmaceuticals ( SWISS : ADXN ), the allosteric modulation company, announced today that in a non-human primate model of Parkinson's disease (PD) levodopa induced dyskinesia (LID), ADX48621 statistically and significantly inhibited LID. More specifically, the ...
GENEVA, SWITZERLAND--(Marketwire - 11/24/09) - ADX48621 shows efficacy on both chorea and dystonia in PD-LID model Addex Pharmaceuticals (Swiss: ADXN - News ), the allosteric modulation company, announced today that in a non-human primate model of Parkinson's disease (PD) levodopa induced dyskinesia (LID), ADX48621 statistically and significantly inhibited LID. More specifically, the compound ...
